Your browser doesn't support javascript.
loading
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke, C; Bergemann, N; Clement, H W; Conca, A; Deckert, J; Domschke, K; Eckermann, G; Egberts, K; Gerlach, M; Greiner, C; Gründer, G; Haen, E; Havemann-Reinecke, U; Hefner, G; Helmer, R; Janssen, G; Jaquenoud, E; Laux, G; Messer, T; Mössner, R; Müller, M J; Paulzen, M; Pfuhlmann, B; Riederer, P; Saria, A; Schoppek, B; Schoretsanitis, G; Schwarz, M; Gracia, M Silva; Stegmann, B; Steimer, W; Stingl, J C; Uhr, M; Ulrich, S; Unterecker, S; Waschgler, R; Zernig, G; Zurek, G; Baumann, P.
Afiliación
  • Hiemke C; Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany.
  • Bergemann N; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.
  • Clement HW; Kitzberg Hospitals, Center for Psychosomatic Medicine and Psychotherapy, Bad Mergentheim, Germany.
  • Conca A; Department of Child and Adolescent Psychiatry, University of Freiburg, Freiburg, Germany.
  • Deckert J; Servizio Psichiatrico del Comprensorio Sanitario di Bolzano, Bolzano, Italy.
  • Domschke K; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
  • Eckermann G; Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Egberts K; Psychiatric Hospital, Kaufbeuren, Germany.
  • Gerlach M; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany.
  • Greiner C; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany.
  • Gründer G; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Haen E; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA - Translational Brain Medicine, Aachen, Germany.
  • Havemann-Reinecke U; Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
  • Hefner G; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany.
  • Helmer R; Psychiatric Hospital, Vitos Klinik, Eichberg, Eltville, Germany.
  • Janssen G; Center of Epilepsy, Bielefeld, Germany.
  • Jaquenoud E; Medical Laboratory Stein, Limbach Group, Mönchengladbach, Germany.
  • Laux G; Psychiatric Hospital, Königsfelden, Brugg, Aargau, Switzerland.
  • Messer T; Institute of Psychological Medicine, Haag in Oberbayern, Germany.
  • Mössner R; Danuviuskliniken, Psychiatric Hospital, Pfaffenhofen, Germany.
  • Müller MJ; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Paulzen M; Psychiatric Hospitals Oberberggruppe, Berlin, Germany.
  • Pfuhlmann B; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA - Translational Brain Medicine, Aachen, Germany.
  • Riederer P; Psychiatric Hospital Weisser Hirsch, Dresden, Germany.
  • Saria A; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
  • Schoppek B; Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria.
  • Schoretsanitis G; kbo-Isar-Amper Klinikum München-Ost, Psychiatric Hospital, Munich-Haar, Germany.
  • Schwarz M; Department of Psychiatry, University of Bern, Bern, Switzerland.
  • Gracia MS; Department of Laboratory Medicine, Ludwig Maximilian University, Munich, Germany.
  • Stegmann B; Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
  • Steimer W; Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
  • Stingl JC; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.
  • Uhr M; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Ulrich S; Max Planck Institute of Psychiatry, Munich, Germany.
  • Unterecker S; Aristo Pharma GmbH, Berlin, Germany.
  • Waschgler R; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
  • Zernig G; Psychiatric Hospital, Feldkirch, Austria.
  • Zurek G; Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria.
  • Baumann P; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria.
Pharmacopsychiatry ; 51(1-02): e1, 2018 01.
Article en En | MEDLINE | ID: mdl-29390205
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Pharmacopsychiatry Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Pharmacopsychiatry Año: 2018 Tipo del documento: Article País de afiliación: Alemania